Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report

Saved in:

Bibliographic Details
Published in	Annals of oncology Vol. 31; no. 7; pp. 961 - 964
Main Authors	Michot, J.-M., Albiges, L., Chaput, N., Saada, V., Pommeret, F., Griscelli, F., Balleyguier, C., Besse, B., Marabelle, A., Netzer, F., Merad, M., Robert, C., Barlesi, F., Gachot, B., Stoclin, A.
Format	Journal Article
Language	English
Published	England Elsevier Ltd 01.07.2020 European Society for Medical Oncology. Published by Elsevier Ltd
Subjects	Adult Antibodies, Monoclonal, Humanized - therapeutic use Autoantibodies - therapeutic use Betacoronavirus Coronavirus Infections - complications Coronavirus Infections - diagnostic imaging Coronavirus Infections - drug therapy COVID-19 Humans Letter to the Editor Male Pandemics Pneumonia, Viral - complications Pneumonia, Viral - diagnostic imaging Pneumonia, Viral - drug therapy Receptors, Interleukin-6 - antagonists & inhibitors Respiratory Insufficiency - diagnostic imaging Respiratory Insufficiency - drug therapy Respiratory Insufficiency - etiology SARS-CoV-2 Treatment Outcome
Online Access	Get full text
ISSN	0923-7534 1569-8041 1569-8041
DOI	10.1016/j.annonc.2020.03.300

Cover

Author	Stoclin, A. Michot, J.-M. Albiges, L. Chaput, N. Besse, B. Balleyguier, C. Gachot, B. Barlesi, F. Saada, V. Netzer, F. Pommeret, F. Robert, C. Merad, M. Griscelli, F. Marabelle, A.
Author_xml	– sequence: 1 givenname: J.-M. surname: Michot fullname: Michot, J.-M. email: jean-marie.michot@gustaveroussy.fr organization: Department of Therapeutic Innovation and Early Testing – sequence: 2 givenname: L. surname: Albiges fullname: Albiges, L. organization: Medical Oncology, University Paris Saclay, Gustave Roussy – sequence: 3 givenname: N. surname: Chaput fullname: Chaput, N. organization: Molecular Analysis, modélisation et imagerie de la Maladie cancéreuse, Laboratoire d’Immunomonitoring en Oncologie, Gustave Roussy, INSERM, CNRS – sequence: 4 givenname: V. surname: Saada fullname: Saada, V. organization: Department of Biology, University Paris Saclay, Gustave Roussy – sequence: 5 givenname: F. surname: Pommeret fullname: Pommeret, F. organization: Medical Oncology, University Paris Saclay, Gustave Roussy – sequence: 6 givenname: F. surname: Griscelli fullname: Griscelli, F. organization: Department of Biology, University Paris Saclay, Gustave Roussy – sequence: 7 givenname: C. surname: Balleyguier fullname: Balleyguier, C. organization: Department of Medical Imaging – sequence: 8 givenname: B. surname: Besse fullname: Besse, B. organization: Medical Oncology, University Paris Saclay, Gustave Roussy – sequence: 9 givenname: A. surname: Marabelle fullname: Marabelle, A. organization: Department of Therapeutic Innovation and Early Testing – sequence: 10 givenname: F. surname: Netzer fullname: Netzer, F. organization: Department of Pharmacy, Villejuif, France – sequence: 11 givenname: M. surname: Merad fullname: Merad, M. organization: Medical Oncology, University Paris Saclay, Gustave Roussy – sequence: 12 givenname: C. surname: Robert fullname: Robert, C. organization: Medical Oncology, University Paris Saclay, Gustave Roussy – sequence: 13 givenname: F. surname: Barlesi fullname: Barlesi, F. organization: Medical Oncology, University Paris Saclay, Gustave Roussy – sequence: 14 givenname: B. surname: Gachot fullname: Gachot, B. organization: Intensive Care Department, Université Paris-Saclay, Gustave Roussy Villejuif, France – sequence: 15 givenname: A. surname: Stoclin fullname: Stoclin, A. organization: Intensive Care Department, Université Paris-Saclay, Gustave Roussy Villejuif, France
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/32247642$$D View this record in MEDLINE/PubMed
BookMark	eNqFUV1rFDEUDVKx2-o_EJlHH5rx5mO--iDI2urCQl9aX0Mmc0ezzE7GJFNYf71Zdyu2DxYCgXvOPSc554ycjG5EQt4yyBmw8sMm12MamZwDhxxELgBekAUryobWINkJWUDDBa0KIU_JWQgbACgb3rwip4JzWZWSL4i9dcYO9te81e1Fpsd0oqWrNS0zjwan6PyfUeu63UUWXRY96pgtb76tPlPWUI-Djtglcpis14m-y3pth9njZaYzowMmbHI-viYvez0EfHO8z8nd9dXt8itd33xZLT-tqSl4EynrUIqGlRKwZpoXfW36FnnVMlHWnZCiSCgWKCtT8_SNvuoTyYDQrAHkTJyTjwfdaW632Bkco9eDmrzdar9TTlv1GBntD_Xd3atq71A2SeD9UcC7nzOGqLY2GBwGPaKbg-KiLtMzQEKivvvX66_JQ76JcHkgGO9C8NgrY6OO1u2t7aAYqH2ZaqMOZap9mQqESmWmZflk-UH_mbVjAJhSvrfoVTAWR4OdTZVG1Tn7f4Hfz9G6gw
CitedBy_id	crossref_primary_10_1016_j_jcv_2020_104380 crossref_primary_10_3390_jpm13101455 crossref_primary_10_3389_fimmu_2021_613070 crossref_primary_10_7759_cureus_9187 crossref_primary_10_1007_s11010_020_03935_z crossref_primary_10_1016_j_ebiom_2022_103920 crossref_primary_10_1128_aac_01350_23 crossref_primary_10_24835_1607_0763_2020_2_96_97 crossref_primary_10_1016_j_bmcl_2020_127571 crossref_primary_10_1089_omi_2020_0122 crossref_primary_10_2217_imt_2020_0136 crossref_primary_10_1186_s42358_024_00397_5 crossref_primary_10_1016_j_ejphar_2021_173890 crossref_primary_10_3390_ijerph17165648 crossref_primary_10_1111_ddg_14169 crossref_primary_10_1097_IPC_0000000000001146 crossref_primary_10_4103_CRST_CRST_129_20 crossref_primary_10_1007_s40267_020_00767_1 crossref_primary_10_55858_IJIMH01012022_39 crossref_primary_10_1016_j_intimp_2020_106760 crossref_primary_10_3389_fphar_2020_577571 crossref_primary_10_4103_ijn_IJN_429_20 crossref_primary_10_1177_09636897211054481 crossref_primary_10_1016_j_jiac_2024_09_013 crossref_primary_10_3904_kjim_2020_417 crossref_primary_10_1080_07391102_2020_1802349 crossref_primary_10_12998_wjcc_v9_i31_9481 crossref_primary_10_3390_pathogens10050565 crossref_primary_10_22207_JPAM_14_3_01 crossref_primary_10_22207_JPAM_14_3_02 crossref_primary_10_3389_fimmu_2020_01841 crossref_primary_10_1186_s40001_020_00438_x crossref_primary_10_1056_NEJMoa2028700 crossref_primary_10_1139_gen_2020_0135 crossref_primary_10_1139_gen_2020_0130 crossref_primary_10_1016_j_clim_2020_108448 crossref_primary_10_1002_ccr3_3485 crossref_primary_10_1093_cid_ciaa812 crossref_primary_10_1038_s43018_020_00120_5 crossref_primary_10_3390_medicina56080377 crossref_primary_10_1093_abt_tbaa025 crossref_primary_10_7861_clinmed_2020_0309 crossref_primary_10_1136_jitc_2020_000984 crossref_primary_10_2174_0126667975269506231108053010 crossref_primary_10_1016_j_jinf_2020_07_008 crossref_primary_10_3390_ijms22041737 crossref_primary_10_1016_j_cytox_2020_100035 crossref_primary_10_48107_CMJ_2020_05_006 crossref_primary_10_32415_jscientia_2021_7_6_28_70 crossref_primary_10_14218_JCTH_2021_00368 crossref_primary_10_1093_jpids_piaa098 crossref_primary_10_1016_j_cegh_2022_100966 crossref_primary_10_1016_j_eclinm_2020_100410 crossref_primary_10_1055_a_1954_5605 crossref_primary_10_3389_fimmu_2020_01708 crossref_primary_10_1007_s40261_020_00969_5 crossref_primary_10_1136_gutjnl_2020_322539 crossref_primary_10_1016_j_cell_2020_08_002 crossref_primary_10_1007_s11481_020_09968_x crossref_primary_10_1016_j_micinf_2020_06_005 crossref_primary_10_1038_s41598_021_85877_0 crossref_primary_10_3389_fphar_2020_583914 crossref_primary_10_1007_s00228_020_03017_5 crossref_primary_10_1016_j_pulmoe_2021_03_008 crossref_primary_10_21518_2079_701X_2022_16_11_88_94 crossref_primary_10_1016_j_biocel_2021_106114 crossref_primary_10_4103_ijmm_IJMM_20_298 crossref_primary_10_18093_0869_0189_2020_30_2_164_172 crossref_primary_10_1016_j_intimp_2020_107018 crossref_primary_10_1098_rsob_200160 crossref_primary_10_1080_14656566_2020_1792884 crossref_primary_10_1007_s11356_022_20984_7 crossref_primary_10_3389_fimmu_2020_586765 crossref_primary_10_1080_03007995_2021_1906637 crossref_primary_10_1016_j_autrev_2020_102559 crossref_primary_10_1097_HS9_0000000000000409 crossref_primary_10_15586_jptcp_v27iSP1_691 crossref_primary_10_3389_fimmu_2020_569611 crossref_primary_10_1007_s42451_020_00205_6 crossref_primary_10_3389_fgene_2021_637362 crossref_primary_10_1186_s13054_020_02925_3 crossref_primary_10_1007_s40259_020_00430_1 crossref_primary_10_1016_j_medcli_2020_07_002 crossref_primary_10_1016_j_blre_2020_100743 crossref_primary_10_1016_j_biopha_2021_111980 crossref_primary_10_1016_j_reumae_2020_05_002 crossref_primary_10_3390_cells9091951 crossref_primary_10_1016_j_autrev_2020_102567 crossref_primary_10_1111_resp_13912 crossref_primary_10_1016_j_ctrv_2020_102068 crossref_primary_10_1038_s43018_020_00122_3 crossref_primary_10_1002_cbf_3725 crossref_primary_10_1016_j_humimm_2021_05_003 crossref_primary_10_1111_all_14462 crossref_primary_10_3389_fpubh_2023_1039782 crossref_primary_10_1002_jmv_25964 crossref_primary_10_1016_j_critrevonc_2020_103120 crossref_primary_10_3390_antiox12061140 crossref_primary_10_1002_jcph_1693 crossref_primary_10_1155_2023_1879554 crossref_primary_10_12998_wjcc_v8_i15_3156 crossref_primary_10_3389_fimmu_2020_01991 crossref_primary_10_1111_cts_12894 crossref_primary_10_1016_j_intimp_2020_106942 crossref_primary_10_1016_j_jfma_2020_10_021 crossref_primary_10_1186_s42358_020_00151_7 crossref_primary_10_1097_XCE_0000000000000237 crossref_primary_10_1007_s43440_020_00152_9 crossref_primary_10_1016_j_ctrv_2020_102063 crossref_primary_10_5937_afmnai38_26326 crossref_primary_10_1007_s12015_020_09987_4 crossref_primary_10_1016_j_aohep_2020_05_001 crossref_primary_10_1093_ecco_jcc_jjaa205 crossref_primary_10_3389_fimmu_2021_692598 crossref_primary_10_38137_vetfarmatoksbulten_769889 crossref_primary_10_1186_s43556_020_00015_y crossref_primary_10_2174_0113892037274719231212044235 crossref_primary_10_18632_aging_202867 crossref_primary_10_2147_TCRM_S313003 crossref_primary_10_1016_j_ejphar_2020_173568 crossref_primary_10_1016_j_intimp_2021_107409 crossref_primary_10_1016_j_xcrm_2020_100016 crossref_primary_10_1177_11779322231171777 crossref_primary_10_3390_ijerph18030955 crossref_primary_10_1007_s00415_020_10149_2 crossref_primary_10_1097_MD_0000000000026533 crossref_primary_10_23868_202012003 crossref_primary_10_1016_j_blre_2022_100931 crossref_primary_10_14412_1995_4484_2020_245_261 crossref_primary_10_1016_j_jtos_2020_05_013 crossref_primary_10_1002_jmv_26288 crossref_primary_10_1002_jmv_27259 crossref_primary_10_3390_ph14060520 crossref_primary_10_1016_j_intimp_2022_108786 crossref_primary_10_1016_j_arcmed_2020_11_006 crossref_primary_10_1016_j_hjdsi_2021_100581 crossref_primary_10_3390_ijms232113564 crossref_primary_10_3390_antibiotics11081078 crossref_primary_10_3389_fmicb_2021_637554 crossref_primary_10_3390_ijms231710103 crossref_primary_10_3389_fphar_2021_623795 crossref_primary_10_3389_fimmu_2020_01201 crossref_primary_10_3389_fonc_2020_562625 crossref_primary_10_3390_ijms21093377 crossref_primary_10_1111_andr_12868 crossref_primary_10_3389_fmed_2020_00480 crossref_primary_10_1002_jmv_28477 crossref_primary_10_1016_j_medcle_2020_07_014 crossref_primary_10_1016_j_intimp_2022_108536 crossref_primary_10_1177_1470320320979097 crossref_primary_10_4078_jrd_2020_27_4_218 crossref_primary_10_1007_s11684_021_0831_z crossref_primary_10_7883_yoken_JJID_2021_046 crossref_primary_10_1111_liv_14766 crossref_primary_10_1097_HS9_0000000000000472 crossref_primary_10_1016_j_jep_2020_113747 crossref_primary_10_12998_wjcc_v8_i17_3763 crossref_primary_10_1016_S0140_6736_20_30858_8 crossref_primary_10_1097_FJC_0000000000000854 crossref_primary_10_35366_102355 crossref_primary_10_2174_1381612826666201125102649 crossref_primary_10_1016_j_berh_2021_101659 crossref_primary_10_3390_molecules26102917 crossref_primary_10_1007_s00011_020_01423_0 crossref_primary_10_2174_1573397116666201029155105 crossref_primary_10_1186_s13037_023_00358_9 crossref_primary_10_1038_s41366_020_0598_3 crossref_primary_10_1016_j_chest_2020_06_006 crossref_primary_10_34172_mejdd_2022_271 crossref_primary_10_1016_j_cytogfr_2022_01_002 crossref_primary_10_3389_fphar_2020_569189 crossref_primary_10_3389_fphar_2024_1405023 crossref_primary_10_1038_s41551_020_00660_2 crossref_primary_10_3390_ijms22020792 crossref_primary_10_2174_2666796701999201021150744 crossref_primary_10_2174_2666796701999201123101730 crossref_primary_10_3389_fmolb_2020_606393 crossref_primary_10_23736_S0375_9393_20_14663_7 crossref_primary_10_1016_j_virusres_2020_198114 crossref_primary_10_1053_j_gastro_2020_05_032 crossref_primary_10_1515_jbcpp_2020_0113 crossref_primary_10_1016_j_arcmed_2020_06_012 crossref_primary_10_3748_wjg_v26_i46_7272 crossref_primary_10_1016_j_lfs_2020_118185 crossref_primary_10_4103_amhs_amhs_266_21 crossref_primary_10_3390_jcm9093045 crossref_primary_10_1007_s43440_020_00155_6 crossref_primary_10_2174_1381612827666210311141512 crossref_primary_10_37881_1_616 crossref_primary_10_3389_fcimb_2021_763687 crossref_primary_10_1016_j_medmal_2020_05_001 crossref_primary_10_17816_CI636443 crossref_primary_10_1016_j_nmni_2020_100745 crossref_primary_10_1016_j_ejphar_2020_173620 crossref_primary_10_5812_iji_108984 crossref_primary_10_1097_MPG_0000000000002809 crossref_primary_10_3390_v15102018 crossref_primary_10_1016_j_cytogfr_2020_10_002 crossref_primary_10_1007_s00109_021_02072_4 crossref_primary_10_1177_17562848231176450 crossref_primary_10_1080_07391102_2020_1779133 crossref_primary_10_2174_1389557522999220128150814 crossref_primary_10_3390_tropicalmed5030112 crossref_primary_10_1007_s12016_021_08912_y crossref_primary_10_1016_j_jcv_2020_104444 crossref_primary_10_1093_rheumatology_keaa325 crossref_primary_10_1055_s_0040_1714648 crossref_primary_10_1016_j_heliyon_2023_e21941 crossref_primary_10_1155_2020_8198963 crossref_primary_10_1186_s12943_021_01363_1 crossref_primary_10_1186_s13099_020_00387_0 crossref_primary_10_1097_SAP_0000000000002790 crossref_primary_10_3389_fimmu_2020_590964 crossref_primary_10_1016_j_nmni_2020_100707 crossref_primary_10_1016_j_clim_2020_108631 crossref_primary_10_2174_2666796701999201123102516 crossref_primary_10_3389_fcimb_2022_933824 crossref_primary_10_1007_s12011_021_02893_x crossref_primary_10_1007_s12035_020_02074_2 crossref_primary_10_1080_2162402X_2020_1807836 crossref_primary_10_1038_s41598_021_88086_x crossref_primary_10_1049_syb2_12079 crossref_primary_10_1007_s00262_023_03524_1 crossref_primary_10_1016_j_ejca_2020_07_009 crossref_primary_10_15252_emmm_202012421 crossref_primary_10_3389_fphar_2024_1431617 crossref_primary_10_1016_j_lfs_2020_118054 crossref_primary_10_1186_s12985_024_02529_1 crossref_primary_10_1080_20961790_2020_1767754 crossref_primary_10_1111_ddg_14169_g crossref_primary_10_1007_s11739_021_02734_8 crossref_primary_10_1016_j_cyto_2024_156756
Cites_doi	10.1016/S0140-6736(20)30183-5 10.1016/j.smim.2014.01.009 10.1016/S0140-6736(13)60250-0 10.1016/S0140-6736(20)30211-7 10.1016/S2213-2600(20)30076-X 10.1182/blood-2014-05-552729 10.1111/j.1365-2249.2004.02415.x 10.1056/NEJMoa2001282 10.1007/s00281-017-0629-x
ContentType	Journal Article
Copyright	2020 European Society for Medical Oncology 2020 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. 2020 European Society for Medical Oncology
Copyright_xml	– notice: 2020 European Society for Medical Oncology – notice: 2020 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. 2020 European Society for Medical Oncology
DBID	AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM
DOI	10.1016/j.annonc.2020.03.300
DatabaseName	CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles)
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1569-8041
EndPage	964
ExternalDocumentID	PMC7136869 32247642 10_1016_j_annonc_2020_03_300 S0923753420363870
Genre	Letter Case Reports Report Correspondence Case Study
GroupedDBID	--- -E4 .2P .86 .I3 .XZ .ZR 08P 0R~ 0U7 1TH 23M 2WC 4.4 482 48X 53G 5GY 5VS 5WA 6.Y 6J9 70D AABJS AABMN AAEDW AAESY AAIAV AAIYJ AAJKP AAJQQ AAKAS AAKUH AAMVS AAOGV AAPNW AAUQX AAXUO ABEUO ABIXL ABJNI ABKDP ABLJU ABNKS ABOCM ABQLI ABQTQ ABSAR ABSMQ ABVKL ABZBJ ACGFO ACGFS ACIMA ACMRT ACPQN ACPRK ACUFI ACUTO ADBBV ADEIU ADEYI ADHKW ADHZD ADJQC ADOCK ADORX ADQLU ADRIX ADRTK ADYVW ADZCM ADZXQ AEGPL AEGXH AEJOX AEKPW AEKSI AEMDU AENEX AENZO AEPUE AEWNT AFIYH AFOFC AFXEN AGINJ AGKEF AGKRT AGSYK AHMBA AHXPO AIAGR AIJHB AIKOY AITUG ALMA_UNASSIGNED_HOLDINGS ALUQC AMRAJ APIBT APWMN AQKUS ASMCH ASPBG ATTQO AVWKF AWCFO AXUDD AZFZN AZQFJ BAWUL BAYMD BEYMZ BGNMA BGYMP BHONS BTRTY BVRKM BZKNY C1A CAG CASEJ CDBKE CKLRP COF CS3 CZ4 DAKXR DIK DILTD DL5 DPORF DPPUQ D~K E3Z EBS EE~ EJD EX3 F9B FDB FEDTE GJXCC GX1 H5~ HAR HVGLF HW0 HZ~ I09 IH2 IHE IOX J21 KAQDR KC5 KDC KOM KOP KQ8 KSI KSN LAK M-Z M41 M49 M4Y MBLQV MHKGH N9A NCXOZ NGC NOYVH NTWIH NU- NU0 NVLIB O9- OAWHX ODMLO OJQWA OK1 OVD P2P P6G PAFKI PB- PEELM PQQKQ Q1. Q5Y QBD R44 RD5 RNI ROL ROX ROZ RPX RW1 RXO RZC RZE RZF RZO SDH TCURE TEORI TJX TMA TR2 U2A W8F WOQ WOW X7H YAYTL YFH YKOAZ ZKX ZXP ~91 AAGQS AALRI AAYWO AAYXX ABNGD ACUKT ACVFH ADCNI ADVLN AEHUL AEUPX AFETI AFJKZ AFPUW AFSHK AGCQF AGQPQ AIGII AKBMS AKRWK AKYEP APXCP CITATION H13 CGR CUY CVF ECM EIF NPM 7X8 EFKBS 5PM
ID	FETCH-LOGICAL-c529t-1de4391640e81a25f8cfbe27b1368d3435391e5e47c82224f7f25fc03a190e213
ISSN	0923-7534 1569-8041
IngestDate	Thu Aug 21 13:54:58 EDT 2025 Fri Sep 05 12:46:00 EDT 2025 Thu Apr 03 07:07:06 EDT 2025 Thu Apr 24 23:08:54 EDT 2025 Tue Jul 01 01:58:39 EDT 2025 Fri Feb 23 02:48:37 EST 2024
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	7
Language	English
License	http://www.elsevier.com/open-access/userlicense/1.0 https://www.elsevier.com/tdm/userlicense/1.0 Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
LinkModel	OpenURL
MergedId	FETCHMERGED-LOGICAL-c529t-1de4391640e81a25f8cfbe27b1368d3435391e5e47c82224f7f25fc03a190e213
Notes	ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Correspondence-3 content type line 23 ObjectType-Report-1 These authors equally contributed.
OpenAccessLink	https://pubmed.ncbi.nlm.nih.gov/PMC7136869
PMID	32247642
PQID	2386435040
PQPubID	23479
PageCount	4
ParticipantIDs	pubmedcentral_primary_oai_pubmedcentral_nih_gov_7136869 proquest_miscellaneous_2386435040 pubmed_primary_32247642 crossref_citationtrail_10_1016_j_annonc_2020_03_300 crossref_primary_10_1016_j_annonc_2020_03_300 elsevier_sciencedirect_doi_10_1016_j_annonc_2020_03_300
ProviderPackageCode	CITATION AAYXX
PublicationCentury	2000
PublicationDate	2020-07-01
PublicationDateYYYYMMDD	2020-07-01
PublicationDate_xml	– month: 07 year: 2020 text: 2020-07-01 day: 01
PublicationDecade	2020
PublicationPlace	England
PublicationPlace_xml	– name: England
PublicationTitle	Annals of oncology
PublicationTitleAlternate	Ann Oncol
PublicationYear	2020
Publisher	Elsevier Ltd European Society for Medical Oncology. Published by Elsevier Ltd
Publisher_xml	– name: Elsevier Ltd – name: European Society for Medical Oncology. Published by Elsevier Ltd
References	Wong, Lam, Wu (bib3) 2004; 136 Gabay, Emery, van Vollenhoven (bib8) 2013; 381 Huang, Wang, Li (bib1) 2020; 395 Conti, Ronconi, Caraffa (bib4) 2020; 34 Xu, Shi, Wang (bib6) 2020; 8 Lee, Gardner, Porter (bib9) 2014; 124 Tanaka, Narazaki, Ogata, Kishimoto (bib7) 2014; 26 Channappanavar, Perlman (bib2) 2017; 39 Chen, Zhou, Dong (bib5) 2020; 395 Cao, Wang, Wen (bib10) 2020; 382 Wong (10.1016/j.annonc.2020.03.300_bib3) 2004; 136 Lee (10.1016/j.annonc.2020.03.300_bib9) 2014; 124 Chen (10.1016/j.annonc.2020.03.300_bib5) 2020; 395 Tanaka (10.1016/j.annonc.2020.03.300_bib7) 2014; 26 Xu (10.1016/j.annonc.2020.03.300_bib6) 2020; 8 Channappanavar (10.1016/j.annonc.2020.03.300_bib2) 2017; 39 Gabay (10.1016/j.annonc.2020.03.300_bib8) 2013; 381 Cao (10.1016/j.annonc.2020.03.300_bib10) 2020; 382 Conti (10.1016/j.annonc.2020.03.300_bib4) 2020; 34 Huang (10.1016/j.annonc.2020.03.300_bib1) 2020; 395
References_xml	– volume: 395 start-page: 507 year: 2020 end-page: 513 ident: bib5 article-title: Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study publication-title: Lancet – volume: 39 start-page: 529 year: 2017 end-page: 539 ident: bib2 article-title: Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology publication-title: Semin Immunopathol – volume: 136 start-page: 95 year: 2004 end-page: 103 ident: bib3 article-title: Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome publication-title: Clin Exp Immunol – volume: 34 start-page: 1 year: 2020 ident: bib4 article-title: Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (CoV-19 or SARS-CoV-2): anti-inflammatory strategies publication-title: J Biol Regul Homeost Agents – volume: 124 start-page: 188 year: 2014 end-page: 195 ident: bib9 article-title: Current concepts in the diagnosis and management of cytokine release syndrome publication-title: Blood – volume: 26 start-page: 88 year: 2014 end-page: 96 ident: bib7 article-title: A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy publication-title: Semin Immunol – volume: 395 start-page: 497 year: 2020 end-page: 506 ident: bib1 article-title: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China publication-title: Lancet – volume: 8 start-page: 420 year: 2020 end-page: 422 ident: bib6 article-title: Pathological findings of COVID-19 associated with acute respiratory distress syndrome publication-title: Lancet Respir Med – volume: 382 start-page: 1787 year: 2020 end-page: 1799 ident: bib10 article-title: A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19 publication-title: N Engl J Med – volume: 381 start-page: 1541 year: 2013 end-page: 1550 ident: bib8 article-title: Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial publication-title: Lancet – volume: 395 start-page: 497 issue: 10223 year: 2020 ident: 10.1016/j.annonc.2020.03.300_bib1 article-title: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China publication-title: Lancet doi: 10.1016/S0140-6736(20)30183-5 – volume: 26 start-page: 88 issue: 1 year: 2014 ident: 10.1016/j.annonc.2020.03.300_bib7 article-title: A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy publication-title: Semin Immunol doi: 10.1016/j.smim.2014.01.009 – volume: 381 start-page: 1541 issue: 9877 year: 2013 ident: 10.1016/j.annonc.2020.03.300_bib8 article-title: Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial publication-title: Lancet doi: 10.1016/S0140-6736(13)60250-0 – volume: 395 start-page: 507 issue: 10223 year: 2020 ident: 10.1016/j.annonc.2020.03.300_bib5 article-title: Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study publication-title: Lancet doi: 10.1016/S0140-6736(20)30211-7 – volume: 34 start-page: 1 issue: 1 year: 2020 ident: 10.1016/j.annonc.2020.03.300_bib4 article-title: Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (CoV-19 or SARS-CoV-2): anti-inflammatory strategies publication-title: J Biol Regul Homeost Agents – volume: 8 start-page: 420 issue: 4 year: 2020 ident: 10.1016/j.annonc.2020.03.300_bib6 article-title: Pathological findings of COVID-19 associated with acute respiratory distress syndrome publication-title: Lancet Respir Med doi: 10.1016/S2213-2600(20)30076-X – volume: 124 start-page: 188 issue: 2 year: 2014 ident: 10.1016/j.annonc.2020.03.300_bib9 article-title: Current concepts in the diagnosis and management of cytokine release syndrome publication-title: Blood doi: 10.1182/blood-2014-05-552729 – volume: 136 start-page: 95 issue: 1 year: 2004 ident: 10.1016/j.annonc.2020.03.300_bib3 article-title: Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome publication-title: Clin Exp Immunol doi: 10.1111/j.1365-2249.2004.02415.x – volume: 382 start-page: 1787 issue: 19 year: 2020 ident: 10.1016/j.annonc.2020.03.300_bib10 article-title: A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19 publication-title: N Engl J Med doi: 10.1056/NEJMoa2001282 – volume: 39 start-page: 529 issue: 5 year: 2017 ident: 10.1016/j.annonc.2020.03.300_bib2 article-title: Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology publication-title: Semin Immunopathol doi: 10.1007/s00281-017-0629-x
SSID	ssj0006929
Score	2.6858547
SourceID	pubmedcentral proquest pubmed crossref elsevier
SourceType	Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	961
SubjectTerms	Adult Antibodies, Monoclonal, Humanized - therapeutic use Autoantibodies - therapeutic use Betacoronavirus Coronavirus Infections - complications Coronavirus Infections - diagnostic imaging Coronavirus Infections - drug therapy COVID-19 Humans Letter to the Editor Male Pandemics Pneumonia, Viral - complications Pneumonia, Viral - diagnostic imaging Pneumonia, Viral - drug therapy Receptors, Interleukin-6 - antagonists & inhibitors Respiratory Insufficiency - diagnostic imaging Respiratory Insufficiency - drug therapy Respiratory Insufficiency - etiology SARS-CoV-2 Treatment Outcome
Title	Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report
URI	https://dx.doi.org/10.1016/j.annonc.2020.03.300 https://www.ncbi.nlm.nih.gov/pubmed/32247642 https://www.proquest.com/docview/2386435040 https://pubmed.ncbi.nlm.nih.gov/PMC7136869
Volume	31
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1569-8041 dateEnd: 20240930 omitProxy: true ssIdentifier: ssj0006929 issn: 0923-7534 databaseCode: DIK dateStart: 19960101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1569-8041 dateEnd: 20240930 omitProxy: true ssIdentifier: ssj0006929 issn: 0923-7534 databaseCode: GX1 dateStart: 19960101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research
link	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkKa9IO50XGQk3pij5uqEN9SBVqCMh23aW-Q4jpapSypIXvY394c4vjZtQYNJVVQ5SZP4fD3-fHzOF4TeBaySGiQBSWKfkaiknBRxkhG_KmFwKQvGVbxj_j05Oo2-nMfno9HNIGup7wqPX_-xruQuVoU2sKuskv0Py7ofhQb4DvaFLVgYtv9mY-jZRX3dX7FCZ2HCp6vJ7BtJ3oMnE8tOpUh2ddFqXyqJpooJTI_PZofEz4iqZRGyhGW15F6xWiar6zpoDsOcWVkYEtmV8HLb8LXQvEwubfUKh0fmnkPUopBrWSoO4Bpl9UPf6YovF-thrFSM9swbhiRg_mnTV02czK4jDBNP7brTsbkpz-X9K6Lt6mtWyUwqSBmEBCZUOuQgjIsGKEnVpKEPNyOJxiodOORMS72bsT3Tiulbw4aOYFx6rGmg0zz5TFL6NlQiqt0AScsrBSXwghFNtCzYhlz3j_kU5v1JmmT30P2AJol8rcbh7KujB0kWaAFI82i2nlMlHW7fwB7atVf7G3XanhptZvgOKNPJQ_TAzHXwRw3cR2gkmsdod26yOZ6geoDfA8wa7NCLLXqxRe8B7lqssIs3sYsH2MUGux8wwxK5WCP3KTr9_OlkekTMqz8Ij4OsI34pVEl4NBGpz4K4SnlViIAWsmvLEDg-7BWxiCiXDDeqaAUH8UnIgOCKwA-foR3oSfECYUF5lPp-xrPSj4BmpJOS07CIGYsZjXg2RqHt1ZwbXXz5epZFbhMgL3NtllyaJZ-EOZhljIg7a6l1YW45nlqD5Ybbas6aAwZvOfOttW8Orl-u57FGtP2vHNg2zCdiGIbH6Lm2t7sXixm47hoS3AFSVn59T1NfKHl5A9_9O5_5Eu2tvMIrtNP97MVroO5d8Ub9FX4DylvuHQ
linkProvider	Flying Publisher
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Tocilizumab%2C+an+anti-IL-6+receptor+antibody%2C+to+treat+COVID-19-related+respiratory+failure%3A+a+case+report&rft.jtitle=Annals+of+oncology&rft.au=Michot%2C+J.-M.&rft.au=Albiges%2C+L.&rft.au=Chaput%2C+N.&rft.au=Saada%2C+V.&rft.date=2020-07-01&rft.pub=European+Society+for+Medical+Oncology.+Published+by+Elsevier+Ltd&rft.issn=0923-7534&rft.eissn=1569-8041&rft.volume=31&rft.issue=7&rft.spage=961&rft.epage=964&rft_id=info:doi/10.1016%2Fj.annonc.2020.03.300&rft_id=info%3Apmid%2F32247642&rft.externalDocID=PMC7136869
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0923-7534&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0923-7534&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0923-7534&client=summon